RxSight, Inc. to Present at the Bank of America Healthcare Conference
RxSight, a specialized ophthalmic medical device company focused on post-cataract surgery vision customization, has announced its participation in the upcoming Bank of America Healthcare Conference in Las Vegas.
The company's management team is set to deliver their presentation on Wednesday, May 14, 2025, at 3:40 PM Pacific Time (6:40 PM Eastern Time). Investors and interested parties can access both the live presentation and archived recording through the company's investor relations website at https://investors.rxsight.com/.
This presentation at a major healthcare conference represents an opportunity for RxSight to showcase their innovations in customized vision solutions for cataract surgery patients. The company's participation in this significant industry event demonstrates their commitment to engaging with the investment community and sharing their business developments.
RxSight, un'azienda specializzata in dispositivi medici oftalmici focalizzata sulla personalizzazione della visione dopo la chirurgia della cataratta, ha annunciato la sua partecipazione alla prossima Bank of America Healthcare Conference a Las Vegas.
Il team di gestione dell'azienda presenterà il proprio intervento mercoledì 14 maggio 2025 alle 15:40 ora del Pacifico (18:40 ora dell'Est). Investitori e interessati potranno seguire la presentazione in diretta e accedere alla registrazione archiviata tramite il sito web delle relazioni con gli investitori all'indirizzo https://investors.rxsight.com/.
Questa presentazione in una conferenza sanitaria di rilievo rappresenta un'opportunità per RxSight di mostrare le proprie innovazioni nelle soluzioni di visione personalizzata per i pazienti sottoposti a chirurgia della cataratta. La partecipazione dell'azienda a questo importante evento del settore dimostra il loro impegno a interagire con la comunità degli investitori e a condividere gli sviluppi aziendali.
RxSight, una empresa especializada en dispositivos médicos oftálmicos centrada en la personalización de la visión tras la cirugía de cataratas, ha anunciado su participación en la próxima Bank of America Healthcare Conference en Las Vegas.
El equipo directivo de la empresa presentará su ponencia el miércoles 14 de mayo de 2025 a las 3:40 PM hora del Pacífico (6:40 PM hora del Este). Los inversores y partes interesadas podrán acceder tanto a la presentación en vivo como a la grabación archivada a través del sitio web de relaciones con inversores de la empresa en https://investors.rxsight.com/.
Esta presentación en una importante conferencia de salud representa una oportunidad para que RxSight muestre sus innovaciones en soluciones de visión personalizadas para pacientes de cirugía de cataratas. La participación de la empresa en este evento relevante del sector demuestra su compromiso de interactuar con la comunidad inversora y compartir sus avances empresariales.
RxSight는 백내장 수술 후 시력 맞춤화에 중점을 둔 전문 안과 의료기기 회사로, 라스베이거스에서 열리는 Bank of America Healthcare Conference에 참가한다고 발표했습니다.
회사의 경영진은 2025년 5월 14일 수요일 태평양 표준시 오후 3시 40분(동부 표준시 오후 6시 40분)에 발표를 진행할 예정입니다. 투자자와 관심 있는 분들은 회사의 투자자 관계 웹사이트 https://investors.rxsight.com/를 통해 생중계 및 녹화 영상을 시청할 수 있습니다.
이 주요 의료 컨퍼런스에서의 발표는 RxSight가 백내장 수술 환자를 위한 맞춤형 시력 솔루션 혁신을 선보일 수 있는 기회를 제공합니다. 회사가 이 중요한 업계 행사에 참여하는 것은 투자자 커뮤니티와 소통하며 사업 발전 상황을 공유하려는 의지를 보여줍니다.
RxSight, une entreprise spécialisée dans les dispositifs médicaux ophtalmiques axée sur la personnalisation de la vision après une chirurgie de la cataracte, a annoncé sa participation à la prochaine Bank of America Healthcare Conference à Las Vegas.
L'équipe de direction de l'entreprise présentera son intervention le mercredi 14 mai 2025 à 15h40 heure du Pacifique (18h40 heure de l'Est). Les investisseurs et parties intéressées pourront accéder à la présentation en direct ainsi qu'à l'enregistrement via le site web des relations investisseurs de l'entreprise à l'adresse https://investors.rxsight.com/.
Cette présentation lors d'une conférence majeure dans le domaine de la santé représente une opportunité pour RxSight de mettre en avant ses innovations en matière de solutions de vision personnalisées pour les patients opérés de la cataracte. La participation de l'entreprise à cet événement important du secteur témoigne de son engagement à dialoguer avec la communauté des investisseurs et à partager ses avancées commerciales.
RxSight, ein auf ophthalmologische Medizinprodukte spezialisiertes Unternehmen mit Fokus auf die individuelle Anpassung der Sehkraft nach Kataraktoperationen, hat seine Teilnahme an der bevorstehenden Bank of America Healthcare Conference in Las Vegas angekündigt.
Das Management-Team des Unternehmens wird seine Präsentation am Mittwoch, den 14. Mai 2025, um 15:40 Uhr Pazifikzeit (18:40 Uhr Ostküstenzeit) halten. Investoren und Interessierte können sowohl die Live-Präsentation als auch die aufgezeichnete Version über die Investor-Relations-Website des Unternehmens unter https://investors.rxsight.com/ abrufen.
Diese Präsentation auf einer bedeutenden Gesundheitskonferenz bietet RxSight die Gelegenheit, ihre Innovationen im Bereich maßgeschneiderter Seh-Lösungen für Patienten nach Kataraktoperationen vorzustellen. Die Teilnahme des Unternehmens an dieser wichtigen Branchenveranstaltung zeigt ihr Engagement, mit der Investorengemeinschaft in Kontakt zu treten und ihre geschäftlichen Entwicklungen zu teilen.
- Management participation in a major healthcare conference increases visibility with institutional investors
- None.
ALISO VIEJO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Bank of America Healthcare Conference in Las Vegas.
RxSight’s management is scheduled to present on Wednesday, May 14, 2025, at 3:40 p.m. Pacific Time / 6:40 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
FAQ
When is RxSight (RXST) presenting at the Bank of America Healthcare Conference 2025?
How can investors watch RxSight's presentation at the BofA Healthcare Conference?
What type of medical devices does RxSight (RXST) specialize in?
Where is the 2025 Bank of America Healthcare Conference with RxSight being held?
What time is RxSight's presentation in Eastern Time at the BofA Healthcare Conference?
